Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence

BACKGROUND: According to the Response Assessment in Neuro-Oncology criteria, new enhancement within the radiation field on contrast enhanced T1-weighted images within 12 weeks after completion of radiotherapy should not qualify for progressive disease, since up to 50% of these cases may be pseudopro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Radbruch, Alexander, Fladt, Joachim, Kickingereder, Philipp, Wiestler, Benedikt, Nowosielski, Martha, Bäumer, Philipp, Schlemmer, Heinz-Peter, Wick, Antje, Heiland, Sabine, Wick, Wolfgang, Bendszus, Martin
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
Imaging
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483046/
https://ncbi.nlm.nih.gov/pubmed/25038253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou129
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky